Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Henrico, VA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Henrico, VA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Lynchburg, VA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Lynchburg, VA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Norfolk, VA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Norfolk, VA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Richmond, VA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Richmond, VA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Virginia Beach, VA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Seattle, WA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Seattle, WA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Tacoma, WA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Wauwatosa, WI
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Birmingham, AL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
El Cajon, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
El Cajon, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Encino, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Encino, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Oceanside, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Oxnard, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Oxnard, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Danbury, CT
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Danbury, CT
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Waterbury, CT
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Waterbury, CT
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Oakwood, GA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Oakwood, GA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Evanston, IL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Evanston, IL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Shawnee Mission, KA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Shawnee Mission, KA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Brockton, MA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Brockton, MA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Saint Louis, MO
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Ocean City, NJ
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Ocean City, NJ
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
North Massapequa, NY
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
North Massapequa, NY
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Beavercreek, OH
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Beavercreek, OH
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Huber Heights, OH
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Huber Heights, OH
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Smithfield, PA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Smithfield, PA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Plano, TX
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Plano, TX
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Saint George, UT
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Saint George, UT
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Kelowna,
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Kelowna,
Click here to add this to my saved trials
Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients
Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients
Status: Enrolling
Updated:  12/31/1969
Augusta University
mi
from
Augusta, GA
Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients
Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients
Status: Enrolling
Updated: 12/31/1969
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Huntsville, AL
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Chandler, AZ
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Chandler, AZ
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Goodyear, AZ
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Goodyear, AZ
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Tucson, AZ
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Tucson, AZ
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Tucson, AZ
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Tucson, AZ
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Tucson, AZ
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Anaheim, CA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Artesia, CA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Artesia, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Carmichael, CA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Carmichael, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Corona, CA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Corona, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Encino, CA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Encino, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Garden Grove, CA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Garden Grove, CA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Glendale, CA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Glendale, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
La Mirada, CA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
La Mirada, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Laguna Hills, CA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Los Angeles, CA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Los Angeles, CA
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials